RAJESH B. PAREKH - 15 Jun 2022 Form 4 Insider Report for Aura Biosciences, Inc. (AURA)

Role
Director
Signature
/s/ Julie Feder, Attorney-in-fact
Issuer symbol
AURA
Transactions as of
15 Jun 2022
Transactions value $
$0
Form type
4
Filing time
17 Jun 2022, 17:09:53 UTC
Previous filing
28 Oct 2021
Next filing
09 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURA Stock Option (Right to Buy) Award $0 +16K $0.00 16K 15 Jun 2022 Common Stock 16K $13.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 15, 2023 or (b) the next annual meeting of the Issuer's stockholders.